Antiandrogenic and apoptotic effects of RU-486 on animal prostate

Journal of Steroid Biochemistry and Molecular Biology

Volumn 104, Issue 3-5, 2007, Pages 321-325

  Cabeza, Marisa ^a   Bratoeff, Eugene ^b   Heuze, Ivonne ^a   Guzmán, Adrián ^a   Gómez, Georgina ^a   Berrios, Hilda ^a   Rosales, Ana María ^a  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Androgen receptors; Apoptosis of prostate cells; Hamster prostate; Mifepristone as antagonist of androgen receptors; Prostate epithelium; Prostate stroma; RU 486

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; GLUCOCORTICOID RECEPTOR; MIBOLERONE; MIFEPRISTONE; PROGESTERONE RECEPTOR; STEROID HORMONE RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; GONADECTOMY; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NICK END LABELING; NONHUMAN; ORGAN WEIGHT; PROSTATE; SYRIAN HAMSTER;

ANDROGEN ANTAGONISTS; ANIMALS; APOPTOSIS; CRICETINAE; DIHYDROTESTOSTERONE; DRUG INTERACTIONS; IMMUNOHISTOCHEMISTRY; MALE; MIFEPRISTONE; PROSTATE; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, ANDROGEN;

ANIMALIA; CRICETINAE; RATTUS;

EID: 34250024032     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.03.009     Document Type: Article

References (17)

1. 2-terminal interaction with the ligand binding domain of the androgen receptor. J. Biol. Chem. 275 (2000) 22986-22994
2. Song L.N., Coghlan M., and Gelmann E.P. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with androgen receptor. Mol. Endocrinol. 18 (2004) 70-85
3. Hodgson M.C., Astapova I., Cheng S., Lee L.J., Verhoeven M.C., Choi E., Balk S.P., and Hollenberg A.N. The androgen receptor recruits nuclear receptor Corepressor (N-Cor) in the presence of mifepristone via its N and C termini reveling a novel molecular mechanism for androgen receptor antagonists. J. Biol. Chem. 289 (2005) 6511-6519
4. Spitz I.M., and Bardin C.W. Mifepristone (RU-486) a modulator of progestin and glucocorticoid action. N. Engl. J. Med. 329 (1993) 404-412
5. Ulman A., Teuch G., and Philibert D. RU 486. Sci. Am. 262 6 (1990) 38-42
6. Wright A.S., Thomas L.N., Douglas R.C., Lazier C.B., and Rittmaster R.S. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of castrated rat. J. Clin. Invest. 98 (1996) 2558-2563
7. Philibert D., Hardy M., Gaillard-Moguilewsky M., Nique F., Tournemine C., and Nédélec L. New analogues of mifepristone with more dissociated atiprogesterone activities. J. Steroid Biochem. 34 (1989) 413-417
8. Raynaud J.P., and Ojasoo T. The design and use of sex-steroid antagonists. J. Steroid Biochem. 58 (1986) 811-833
9. Philibert D., Mogulewsky M., Mary I., Lacaque D., Tournemine C., Secchi J., and Deraedt R. Pharmacological profile of RU 486 in animals. In: Segal S.J., and Baulieu E.E. (Eds). Antiprogestin Steroid RU 486 and Human Fertility Control (1985), Plenum Press, New York 49-86
10. Hendry W.J., and Danzo B.J. Structural conversion of cytosolic steroids receptors by an age-dependent epididymal protease. J. Steroid Biochem. 23 (1985) 883-893
11. Cabeza M., Heuze I., Sánchez M., Bratoeff E., Ramírez E., et al. Relative binding affinity of novel steroids to androgen receptors in hamster prostate. J. Enzyme Inh. Med. Chem. 20 (2005) 357-364
12. Bradford M.M. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1986) 248-254
13. Cabeza M., Vilchis F., Lemus A., Diaz de León L., and Pérez-Palacios G. Molecular interactions of levonorgestrel and its 5α-reduced derivative with androgen receptors in hamster flanking organs. Steroids 60 (1995) 630-635
14. Liang T., and Heiss E. Inhibition of 5α-reductase, receptor binding and nuclear uptake of androgens in the prostate by 4-methyl-4-aza-steroid. J. Biol. Chem. 256 (1981) 7998-8005
15. Sánchez-Criado J.E., Bellido C., Tebar M., Ruiz A., and González D. The antiprogestin RU486 dissociates LH and FSH secretion in male rats: evidence of direct action in pituitary level. J. Endocrinol. 160 (1999) 197-203
16. Rittmaster R.S., Manning A.P., Wrigth A.S., Thomas L.N., Whitefield S., Norman R.W., Lazier C.B., and Rowden G. Evidence of atrophy and apoptosis in ventral prostate of rats given 5α-reductase inhibitor finasteride. Endocrinology 136 (1995) 741-748
17. Imperato-McGinley J., Gautier T., Zirinski K., Hom T., Palomo O., Stein E., Vaughan E.D., Markisz J.A., Ramírez de Arellano E., and Kazam E. Prostate visualization studies in males homozygous and heterozygous for 5α-eductase deficiency. J. Clin. Endocrinol. Metab. 75 (1992) 1022-1026